Chemical Structure (Gabapenin 01)
Gabapentin Capsule
Product Images NDC 69367-345
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 69367-345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Gabapenin 02)
The text describes a graph showing the mean pain score during a 4-week fixed dose period and a d-week dose titration period. The graph compares the pain scores of a placebo group with those of a group taking 3,600 mg/day of Gabapentin. The graph displays the pain score for each week, ranging from Baseline to Week 7.*
Figure 2 (Gabapenin 03)
This appears to be a chart or graph of pain scores over a period of time with different treatment types. It shows a baseline score, followed by scores at weeks 1-7. The types of treatment include a placebo, gabapentin at a dose of 1,800 mg/day, and gabapentin at a dose of 2,400 mg/day. However, the chart is not very clear and is missing some important information, so it is difficult to give a more specific description.*
Figure 3 (Gabapenin 04)
This text appears to be a table of percentages and statistical symbols, with references to "Study 1" and "Study 2". There is not enough information to provide a specific description or analysis of the content.*
Figure 4 (Gabapenin 05)
Principal Display Panel (100 mg Capsule Bottle Label)
This is a medication description for Gabapentin Capsules with a strength of 100 mg of gabapentin, USP per capsule. The usual dosage is not provided, and it is suggested to refer to the package insert for full prescribing information. The capsules should be stored between 15° to 30°C (59° to 86°F) and should be dispensed in child-resistant containers. The manufacturer is GSPC Ouyi Pharmaceutical Co., Ltd., located in Shijazhuang, Hebei, China, and is manufactured for Westminster Pharmaceuticals, LLC, located in Nashville, TN. The medication guide should be separately provided to each patient by the pharmacist. The package contains 100 capsules.*
Principal Display Panel (300 mg Capsule Bottle Label)
Each capsule of Gabapentin contains 300 mg of Gabapentin USP. The usual dosage and prescribing information can be found in the package insert. The capsules are manufactured by CSPC Ouyi Pharmaceutical Co, Ltd and distributed by Westminster Pharmaceuticals, LLC. The medication should be stored in child-resistant containers at controlled room temperature. The prescription includes 100 capsules. Pharmacists are advised to provide each patient with a medication guide.*
Principal Display Panel (400 mg Capsule Bottle Label)
This description provides information about Gabapentin Capsules, which are a medication containing 400 mg of gabapentin. The medication is dispensed in bottles with 100 capsules inside, each capsule is 18*50mm in size. The usual dosage is indicated to be found in the package insert, and the medication should be stored between 15° to 30°C. The manufacturer of the medication is CSPC Ouyi Pharmaceutical Co. Ltd located in Shijiazhuang, Hebei, China. The medication is distributed by Westminster Pharmaceuticals, LLC in Nashville, TN. The medication guide must be dispensed to each patient; pharmacists should provide further guidance.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
